Intermediate hepatocellular carcinoma: The role of transarterial therapy

Fabrizio Chegai, Antonio Orlacchio, Stefano Merolla, Serena Monti, Lorenzo Mannelli

Research output: Contribution to journalReview article

Abstract

According to Barcelona Clinic Liver Cancer, the recommended first-line treatment for patients with intermediate stage of hepatocellular carcinoma (HCC) is transarterial chemoembolization. Patients with intermediate stage of HCC represent 20% with a 2-year survival of approximately 50%. Nowadays, transarterial therapies have proved precious in the treatment of hepatic malignancies. During the last years, there were important developments in practiced transarterial therapies and their efficacy is still controversial. The purpose of this review is to discuss in further details these transarterial therapies that have been used to treat cases of HCC.

Original languageEnglish
Pages (from-to)399-408
Number of pages10
JournalHepatic Oncology
Volume2
Issue number4
DOIs
Publication statusPublished - Oct 1 2015

Fingerprint

Hepatocellular Carcinoma
Therapeutics
Liver Neoplasms
Survival
Liver
Neoplasms

Keywords

  • chemoembolization
  • DEB TACE
  • embolization
  • hepatocellular carcinoma
  • interventional treatment
  • radioembolization
  • transarterial chemo-occlusion
  • transarterial therapy

ASJC Scopus subject areas

  • Hepatology
  • Oncology

Cite this

Intermediate hepatocellular carcinoma : The role of transarterial therapy. / Chegai, Fabrizio; Orlacchio, Antonio; Merolla, Stefano; Monti, Serena; Mannelli, Lorenzo.

In: Hepatic Oncology, Vol. 2, No. 4, 01.10.2015, p. 399-408.

Research output: Contribution to journalReview article

Chegai, Fabrizio ; Orlacchio, Antonio ; Merolla, Stefano ; Monti, Serena ; Mannelli, Lorenzo. / Intermediate hepatocellular carcinoma : The role of transarterial therapy. In: Hepatic Oncology. 2015 ; Vol. 2, No. 4. pp. 399-408.
@article{e9bd7e1c9f9f46b4a73fb3b4dbb3af7c,
title = "Intermediate hepatocellular carcinoma: The role of transarterial therapy",
abstract = "According to Barcelona Clinic Liver Cancer, the recommended first-line treatment for patients with intermediate stage of hepatocellular carcinoma (HCC) is transarterial chemoembolization. Patients with intermediate stage of HCC represent 20{\%} with a 2-year survival of approximately 50{\%}. Nowadays, transarterial therapies have proved precious in the treatment of hepatic malignancies. During the last years, there were important developments in practiced transarterial therapies and their efficacy is still controversial. The purpose of this review is to discuss in further details these transarterial therapies that have been used to treat cases of HCC.",
keywords = "chemoembolization, DEB TACE, embolization, hepatocellular carcinoma, interventional treatment, radioembolization, transarterial chemo-occlusion, transarterial therapy",
author = "Fabrizio Chegai and Antonio Orlacchio and Stefano Merolla and Serena Monti and Lorenzo Mannelli",
year = "2015",
month = "10",
day = "1",
doi = "10.2217/hep.15.32",
language = "English",
volume = "2",
pages = "399--408",
journal = "Hepatic Oncology",
issn = "2045-0923",
publisher = "Future Medicine Ltd.",
number = "4",

}

TY - JOUR

T1 - Intermediate hepatocellular carcinoma

T2 - The role of transarterial therapy

AU - Chegai, Fabrizio

AU - Orlacchio, Antonio

AU - Merolla, Stefano

AU - Monti, Serena

AU - Mannelli, Lorenzo

PY - 2015/10/1

Y1 - 2015/10/1

N2 - According to Barcelona Clinic Liver Cancer, the recommended first-line treatment for patients with intermediate stage of hepatocellular carcinoma (HCC) is transarterial chemoembolization. Patients with intermediate stage of HCC represent 20% with a 2-year survival of approximately 50%. Nowadays, transarterial therapies have proved precious in the treatment of hepatic malignancies. During the last years, there were important developments in practiced transarterial therapies and their efficacy is still controversial. The purpose of this review is to discuss in further details these transarterial therapies that have been used to treat cases of HCC.

AB - According to Barcelona Clinic Liver Cancer, the recommended first-line treatment for patients with intermediate stage of hepatocellular carcinoma (HCC) is transarterial chemoembolization. Patients with intermediate stage of HCC represent 20% with a 2-year survival of approximately 50%. Nowadays, transarterial therapies have proved precious in the treatment of hepatic malignancies. During the last years, there were important developments in practiced transarterial therapies and their efficacy is still controversial. The purpose of this review is to discuss in further details these transarterial therapies that have been used to treat cases of HCC.

KW - chemoembolization

KW - DEB TACE

KW - embolization

KW - hepatocellular carcinoma

KW - interventional treatment

KW - radioembolization

KW - transarterial chemo-occlusion

KW - transarterial therapy

UR - http://www.scopus.com/inward/record.url?scp=84984993638&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84984993638&partnerID=8YFLogxK

U2 - 10.2217/hep.15.32

DO - 10.2217/hep.15.32

M3 - Review article

VL - 2

SP - 399

EP - 408

JO - Hepatic Oncology

JF - Hepatic Oncology

SN - 2045-0923

IS - 4

ER -